NVDA+0.07%AAPL+2.35%GOOGL+0.66%MSFT+1.30%AMZN+2.03%TSM+0.14%SPCX-1.93%AVGO-4.10%META+1.65%TSLA+3.49%LLY+4.08%SKHY+2.31%BRK-B-0.24%MU-0.25%JPM-1.42%WMT+0.06%AMD-3.63%XOM+0.69%V+1.56%ASMLa-2.22%JNJ+0.63%0700.HK+1.08%MA+0.59%INTC-3.30%ABBV+1.55%BAC-1.38%1398.HK+1.51%CSCO+0.30%COST+0.57%CVX+0.52%ORCL+2.01%AP2d-2.89%AMAT-4.04%LRCX-5.68%KO+1.02%GE-4.85%CAT-3.73%0005.HK-0.56%UNH-1.35%HSBA.L-1.15%PG+0.29%HD+1.52%MS-0.78%NFLX+3.52%0857.HK+1.63%BABA+0.74%9988.HK-1.97%NVS+2.66%RTX-1.76%GS-1.47%USDCHF-1.73%CADCHF-1.31%GBPCHF-1.21%CHFJPY+1.19%AUDCHF-1.14%CHFSGD+1.14%USDPLN-1.04%NZDCHF-1.03%USDZAR-1.01%USDSEK-1.00%USDNOK-0.91%EURCHF-0.90%EURUSD+0.85%USDTHB-0.84%USDDKK-0.81%EURHKD+0.77%CHFNOK+0.75%NZDUSD+0.70%CHFSEK+0.66%USDMXN-0.63%AUDUSD+0.58%GBPUSD+0.58%EURCNH+0.57%USDJPY-0.56%USDSGD-0.53%NZDSGD+0.49%GBPZAR-0.44%USDCAD-0.43%GBPTRY+0.41%EURCAD+0.39%NZDMXN+0.38%AUDNOK-0.35%GBPHKD+0.32%EURGBP+0.29%NZDCAD+0.29%GBPMXN-0.28%EURSGD+0.28%EURAUD+0.28%PLNJPY+0.27%EURJPY+0.26%AUDDKK-0.24%SGDJPY-0.24%EURPLN-0.24%USDCNH-0.21%EURZAR-0.20%EURSEK-0.20%NZDJPY+0.16%USDILS+0.16%GBPNZD-0.14%GBPCAD+0.14%NOKJPY+0.14%EURCZK-0.13%CADJPY-0.13%AUDNZD-0.13%AUDCAD+0.13%USDTRY+0.12%EURNZD+0.12%EURNOK-0.10%USDHKD-0.09%GBPSGD+0.04%USDCOP-0.04%AUDSGD+0.04%GBPAUD+0.01%EURDKK0.00%GBPJPY0.00%AUDJPY0.00%XPTUSD+5.43%XAGUSD+4.10%GAGUSD+4.09%GAUUSD+3.71%XAUUSD+3.71%COTTON+2.89%W1+2.31%XNGUSD+1.19%C1+1.19%COCOA+1.14%S1+1.14%USOIL+1.04%BTCUSDT-9.52%BTCUSD+6.83%ETHUSD+9.32%USDTUSD+0.03%BNBUSDT-1.66%XRPUSD+6.32%SOLUSD+6.34%TRXUSDT+0.20%DOGEUSD+4.13%ZECUSDT+9.74%ADAUSDT-27.38%XMRUSDT+1.51%LINKUSD+3.25%XLMUSDT-5.04%XLMUSD+4.96%BCHUSDT+2.51%AVAXUSDT-29.25%SUIUSDT-26.97%LTCUSD+2.86%TONUSDT+27.64%TONUSD+30.10%HBARUSDT+2.94%SUIUSD+5.46%UNIUSD+7.45%TAOUSDT+3.39%UNIUSDT+10.02%NEARUSDT+22.51%AAVEUSD+5.56%ETCUSDT-24.79%DOTUSDT+1.83%ICPUSDT+1.45%PEPEUSD+9929986.05%ONDOUSDT+4.85%WLDUSDT+7.76%ATOMUSDT+1.87%JUPUSDT+4.12%ARBUSDT+6.18%INJUSDT+2.91%PENGUUSDT+102525.63%FETUSDT+4.31%TIAUSDT+4.71%SEIUSDT+4.81%PYTHUSDT+3.86%STXUSDT+5.46%IMXUSDT+1.86%OPUSDT+4.43%FARTCOINUSDT+8.46%POLUSDT-1.04%NVDA+0.07%AAPL+2.35%GOOGL+0.66%MSFT+1.30%AMZN+2.03%TSM+0.14%SPCX-1.93%AVGO-4.10%META+1.65%TSLA+3.49%LLY+4.08%SKHY+2.31%BRK-B-0.24%MU-0.25%JPM-1.42%WMT+0.06%AMD-3.63%XOM+0.69%V+1.56%ASMLa-2.22%JNJ+0.63%0700.HK+1.08%MA+0.59%INTC-3.30%ABBV+1.55%BAC-1.38%1398.HK+1.51%CSCO+0.30%COST+0.57%CVX+0.52%ORCL+2.01%AP2d-2.89%AMAT-4.04%LRCX-5.68%KO+1.02%GE-4.85%CAT-3.73%0005.HK-0.56%UNH-1.35%HSBA.L-1.15%PG+0.29%HD+1.52%MS-0.78%NFLX+3.52%0857.HK+1.63%BABA+0.74%9988.HK-1.97%NVS+2.66%RTX-1.76%GS-1.47%USDCHF-1.73%CADCHF-1.31%GBPCHF-1.21%CHFJPY+1.19%AUDCHF-1.14%CHFSGD+1.14%USDPLN-1.04%NZDCHF-1.03%USDZAR-1.01%USDSEK-1.00%USDNOK-0.91%EURCHF-0.90%EURUSD+0.85%USDTHB-0.84%USDDKK-0.81%EURHKD+0.77%CHFNOK+0.75%NZDUSD+0.70%CHFSEK+0.66%USDMXN-0.63%AUDUSD+0.58%GBPUSD+0.58%EURCNH+0.57%USDJPY-0.56%USDSGD-0.53%NZDSGD+0.49%GBPZAR-0.44%USDCAD-0.43%GBPTRY+0.41%EURCAD+0.39%NZDMXN+0.38%AUDNOK-0.35%GBPHKD+0.32%EURGBP+0.29%NZDCAD+0.29%GBPMXN-0.28%EURSGD+0.28%EURAUD+0.28%PLNJPY+0.27%EURJPY+0.26%AUDDKK-0.24%SGDJPY-0.24%EURPLN-0.24%USDCNH-0.21%EURZAR-0.20%EURSEK-0.20%NZDJPY+0.16%USDILS+0.16%GBPNZD-0.14%GBPCAD+0.14%NOKJPY+0.14%EURCZK-0.13%CADJPY-0.13%AUDNZD-0.13%AUDCAD+0.13%USDTRY+0.12%EURNZD+0.12%EURNOK-0.10%USDHKD-0.09%GBPSGD+0.04%USDCOP-0.04%AUDSGD+0.04%GBPAUD+0.01%EURDKK0.00%GBPJPY0.00%AUDJPY0.00%XPTUSD+5.43%XAGUSD+4.10%GAGUSD+4.09%GAUUSD+3.71%XAUUSD+3.71%COTTON+2.89%W1+2.31%XNGUSD+1.19%C1+1.19%COCOA+1.14%S1+1.14%USOIL+1.04%BTCUSDT-9.52%BTCUSD+6.83%ETHUSD+9.32%USDTUSD+0.03%BNBUSDT-1.66%XRPUSD+6.32%SOLUSD+6.34%TRXUSDT+0.20%DOGEUSD+4.13%ZECUSDT+9.74%ADAUSDT-27.38%XMRUSDT+1.51%LINKUSD+3.25%XLMUSDT-5.04%XLMUSD+4.96%BCHUSDT+2.51%AVAXUSDT-29.25%SUIUSDT-26.97%LTCUSD+2.86%TONUSDT+27.64%TONUSD+30.10%HBARUSDT+2.94%SUIUSD+5.46%UNIUSD+7.45%TAOUSDT+3.39%UNIUSDT+10.02%NEARUSDT+22.51%AAVEUSD+5.56%ETCUSDT-24.79%DOTUSDT+1.83%ICPUSDT+1.45%PEPEUSD+9929986.05%ONDOUSDT+4.85%WLDUSDT+7.76%ATOMUSDT+1.87%JUPUSDT+4.12%ARBUSDT+6.18%INJUSDT+2.91%PENGUUSDT+102525.63%FETUSDT+4.31%TIAUSDT+4.71%SEIUSDT+4.81%PYTHUSDT+3.86%STXUSDT+5.46%IMXUSDT+1.86%OPUSDT+4.43%FARTCOINUSDT+8.46%POLUSDT-1.04%

CRINETICS PHARMACEUTICALS INC (CRNX)

NASDAQ • Healthcare

$84.72

-$0.03 (-0.0%)

Market open

Last close at August 18, 2026 at 20:00 UTC

Fundamentals Charts

About CRINETICS PHARMACEUTICALS INC

Name

CRINETICS PHARMACEUTICALS INC

CEO

R. Scott Struthers

Website

www.crinetics.com

Industry

Healthcare

Year Founded

2008

Employees

594

Crinetics Pharmaceuticals, Inc. is a NASDAQ-listed biotechnology company developing oral drug candidates for endocrine disorders and related tumors. In qualitative terms, it is a clinical-stage pharmaceutical enterprise rather than a commercial drugmaker, with its work centered on non-peptide therapies that target hormone-signaling pathways.

Fundamentals & Financials

Revenue (TTM)

$42.1M

Net Income (TTM)

-$501.6M

EPS (TTM)

-$5.05

ROA (TTM)

-37.95%

Current Ratio

15.57

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Income Statement

Item	Q2 FY2026	Q1 FY2026	Q4 FY2025
Revenue	$25,118K	$10,734K	$6,161K
Cost of Sales	$154,000	$200,000	$0
Gross Profit	$24,964K	$10,534K	$6,161K
Operating Income	-$132,459K	-$140,378K	-$133,666K
Net Income	-$120,855K	-$127,845K	-$122,815K
EPS	-$1.14	-$1.23	-$1.3